The Pharmaceutical Opinion Program (POP), implemented April 1, 2011 by the Ministry of Health and Long-Term Care, is a clinical intervention that occurs at the time of dispensing a prescription or when conducting a MedsCheck review, in which a pharmacist identifies a potential concern that requires consultation with the prescriber. Based on this, the medication may be dispensed as prescribed, it may not be dispensed, or the therapy may be adjusted or changed. The POP allows pharmacists to bill for these consultations when provided to Ontario Drug Benefit (ODB) patients.
The Ontario Pharmacists Association has developed a standardized documentation tool to simplify the process for both pharmacists and prescribers. Click here to access these tools.